title: HPV infections: can they be eradicated using nanotechnology?
abstract: Human papillomavirus (HPV) infections are considered the most common sexually transmitted diseases, with more than 450 million people worldwide infected. HPVs can cause anogenital warts and neoplasias. One prevalent cancer type caused by HPV (mostly type 16 and 18) is cervical intraepithelial neoplasia (CIN). Nanotechnology tools employed in the development of vaccines and a noninvasive treatment may provide a significant advancement in the global combat against this disease.
authors.affiliation: School of Pharmacy, Waterloo Institute of Nanotechnology, University of Waterloo, Waterloo, Ontario, Canada. foldvari@uwaterloo.ca
authors.forename: Marianna
authors.initials: M
authors.lastname: Foldvari
mesh_terms: D000287:Administration, Topical; D016503:Drug Delivery Systems; D052162:Human papillomavirus 16 / Q000472:pathogenicity; D052161:Human papillomavirus 18 / Q000472:pathogenicity; D006801:Humans; D016898:Interferon-alpha / Q000378:metabolism; D053758:Nanoparticles / Q000627:therapeutic use*; D036103:Nanotechnology / Q000379:methods*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology
chemical_list: D016898:Interferon-alpha; D053918:Papillomavirus Vaccines